Researchers Build 11,000-Sample RNA Aging Clock Across 4 Species
Updated
Updated · ScienceAlert · Jun 4
Researchers Build 11,000-Sample RNA Aging Clock Across 4 Species
3 articles · Updated · ScienceAlert · Jun 4
Summary
More than 11,000 samples from mice, rats, macaques and humans were used to build a transcriptomic clock that estimates biological age and expected mortality from RNA activity.
The model tracked gene-expression patterns tied to slower aging—such as cell division and wound repair—and faster aging, including inflammation and cell death, then held up against other aging models.
Human blood tests predicted time to death about as well as leading epigenetic clocks, while animal and patient tissue data showed the tool also captures chronic-disease signals linked to accelerated aging.
Because the same aging-related biomarkers appeared across organs and species, researchers say the clock could help test drugs or lifestyle interventions faster, though it still needs broader validation in diverse human populations.
Can a simple RNA test now reveal your true biological age and predict your remaining lifespan?
What are the hidden dangers and ethical pitfalls of knowing your body's precise biological age?
Three years on, how is this revolutionary 'biological clock' changing the hunt for anti-aging drugs?
The RNA Aging Clock: Revolutionizing Biological Age Measurement and Personalized Longevity Therapies
Overview
A major breakthrough in aging research was achieved with the development of the RNA aging clock, published in Nature in June 2026. This novel method measures biological age by analyzing shared gene signatures, revealing how mammals age at a molecular level. Scientists identified conserved signatures and a modular architecture of mortality regulation across species and tissues, marking a pivotal step in understanding aging. This modular framework not only allows precise quantification of aging processes but also enables targeted interventions within specific cellular subsystems, opening new possibilities for personalized longevity therapies and advancing our grasp of the fundamental biology of aging.